ArticleClinical genitourinary cancer2022

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.

Rafee Talukder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.